Stocks · News reference

Freedom Capital Markets Maintains Hold on Doximity, Raises Price Target to $32

2026-11-10 12:46:55 UTCBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Fiscal.ai2026-11-09 19:03:30 UTC
Doximity Expands AI Tools and Reports Growth in AI Search Advertising
Doximity is expanding its AI-driven clinical tools and advertising business, reporting significant growth in health system adoption and bookings for its AI Search advertising product.
DOCS
Fiscal.ai2026-11-09 02:02:19 UTC
Doximity, Inc. Reports Second-Quarter Revenue Beat
Doximity, Inc. announced its second-quarter financial results, reporting revenue of $174.54 million, which exceeded analyst expectations.
DOCS
Fiscal.ai2026-11-06 19:03:09 UTC
RBC Capital Markets Raises Price Target on Doximity
RBC Capital Markets increased its price target for Doximity, Inc. (NYSE: DOCS) from $28 to $34 while maintaining an "Outperform" rating.
DOCS
Benzinga2026-11-06 18:18:32 UTCBenzinga Newsdesk
RBC Capital Maintains Outperform on Doximity, Raises Price Target to $34
DOCS
Benzinga2026-11-06 14:44:06 UTCBenzinga Newsdesk
Evercore ISI Group Maintains In-Line on Doximity, Lowers Price Target to $33
DOCS
Fiscal.ai2026-11-04 17:32:25 UTC
Dr. Martens plc Admits Additional Shares to Trading
Dr. Martens plc has admitted 94,286 new ordinary shares to the London Stock Exchange Main Market in connection with employee share schemes.
DOCS